The present invention is generally directed to fuel cell components, and to solid oxide fuel cell electrolyte materials in particular.
Fuel cells are electrochemical devices which can convert chemical energy stored in fuels to electrical energy with high efficiencies. They comprise an electrolyte between electrodes. Solid oxide fuel cells (SOFCs) are characterized by the use of a solid oxide as the electrolyte.
In solid oxide fuel cell (SOFC) system, an oxidizing flow is passed through the cathode side of the fuel cell while a fuel flow is passed through the anode side of the fuel cell. The oxidizing flow is typically air, while the fuel flow can be a hydrocarbon fuel, such as methane, natural gas, pentane, ethanol, or methanol. The fuel cell, operating at a typical temperature between 650° C. and 950° C., enables the transport of negatively charged oxygen ions from the cathode flow stream to the anode flow stream, where the ion combines with either free hydrogen or hydrogen in a hydrocarbon molecule to form water vapor and/or with carbon monoxide to form carbon dioxide. The excess electrons from the negatively charged ion are routed back to the cathode side of the fuel cell through an electrical circuit completed between anode and cathode, resulting in an electrical current flow through the circuit.
In recent years considerable interest has been shown towards the development of SOFC electrolyte compositions of high ionic conductivity. Doped cerium oxide, lanthanum gallate and zirconium oxide are the most suitable candidates. However, in order to achieve sufficient ionic conductivity high operation temperature is often required, deteriorating the life of the fuel cell components and requiring the use of expensive materials in the fuel cell stack, such as chromium alloy interconnects. Therefore, it is highly desirable to lower the operation temperature of SOFCs and one important step to achieve this is the development of an electrolyte composition with higher ionic conductivity than yttria-stabilized zirconia (YSZ), the state of the art SOFC electrolyte material.
Doping zirconia with aliovalent dopants stabilizes the high temperature cubic fluorite phase at room temperature leading to an increase in oxygen vacancy concentration, oxygen mobility and ionic conductivity. Complex studies have demonstrated a correlation between the dopant and host ionic radii and the existence of a critical dopant cation radius that can ensure maximum conductivity. It has been suggested that a good evaluation of the relative ion mismatch between dopant and host would be to compare the cubic lattice parameter of the host oxide and the pseudocubic lattice parameter of the dopant oxide, a smaller size mismatch being preferred for obtaining high ionic conductivity.
Numerous attempts to find the appropriate dopant for stabilizing the cubic phase have been made (Y, Yb, Ce, Bi, etc). Among these, scandia stabilized zirconia shows the highest ionic conductivity with Sc3+ concentration of 11 mole % (2-3 higher than YSZ at 800° C.) due to a lower activation energy than YSZ. The complex phase diagram in the Sc2O3—ZrO2 system is still under debate, with several phases identified in the dopant rich segment of the phase diagram, as monoclinic, tetragonal and rhombohedral intermediate phases appear at low temperatures. One example is the distorted rhombohedral β phase (Sc2Zr7O17), that undergoes a rhombohedral-cubic phase transition around 600-700° C. and induces a steep decrease in conductivity in this temperature region. This transition is not favorable from the point of view of thermal expansion mismatch and may be related to order-disorder transition of oxygen vacancies.
Co-doping in zirconia systems may produce cheaper, stable compositions with enhanced ionic conductivity. Co-dopants in the scandia zirconia system include Ce, Y, Yb and Ti, the former (1 mole % CeO2) being the most successful to date in stabilizing the cubic phase at room temperature and very high conductivity values have been measured by Lee et al, 135 mS/cm at 800° C. in air (SSI 176 (1-2) 33-3 (2005)). However, concerns about long term stability, especially at the interface with the fuel electrode, due to Ce3+ presence, have been reported.
In general, CaO or MgO are used for improving the toughness of zirconia ceramics by stabilizing the tetragonal phase at room temperature.
However, previous studies for doping zirconia with alkaline earth metal cations alone have been unsuccessful in improving the conductivity because of a high tendency of defect association and a lower thermodynamic stability of cubic fluorite ZrO2—CaO and ZrO2—MgO solid solutions.
A solid oxide fuel cell (SOFC) electrolyte composition includes zirconia stabilized with scandia, and at least one of magnesia, zinc oxide, indium oxide, and gallium oxide, and optionally ceria.
Another embodiment of the invention provides an electrolyte composition for a solid oxide fuel cell that includes zirconia stabilized with scandia and indium oxide, in which scandia and indium oxide are present in total amount that is greater than or equal to 10 mol % and less than or equal to 13 mol %. Another embodiment of the invention provides zirconia stabilized with scandia, indium oxide, and ceria, in which scandia, indium oxide, and ceria are present in a total amount that is greater than or equal to 8 mol % and less than or equal to 14 mol %, such as 11 mol %.
The various embodiments provide compositions of an electrolyte for a SOFC which includes a doped scandia stabilized zirconia. In an embodiment, zirconia is co-doped with scandium and aliovalent atoms and is made by co-precipitation.
As both phase composition and conductivity may be very much dependant on the synthesis conditions, numerous studies have focused on developing technologies for synthesis and sintering. Solid state synthesis is known to lead to phase inhomogeneity due to the slow kinetics for cation migration, therefore high sintering temperatures may be required for phase formation. Alternative techniques such as co-precipitation, combustion and sol-gel may prove to be more successful in achieving compositional homogeneity and high extent of densification.
In the various embodiments, powder may be obtained using co-precipitation, which includes dissolving stoichiometric amounts of scandium, and at least one of magnesium oxide or carbonate, zinc oxide, indium oxide and/or gallium oxide (and optionally yttrium oxide in addition to the above oxides depending on the composition) in hot HNO3 followed by mixing with and aqueous solution in which zirconium acetylacetonate or other Zr precursor compound has been dissolved. The mixture may be stirred under heating on a hot plate then cooled down to room temperature and precipitated with ammonia until pH=9. The formed precipitate may be filtrated, dried and calcined at 1200° C. for 5 hours. The resulting powder may be crushed, ball milled and pressed into pellets and bars to be sintered to dense bodies at 1500-1550° C. for 7 hours. The sintered product may be characterised using X-ray diffraction, particle size analysis, SEM, TEM and conductivity measurements. To obtain an accurate value of the ionic conductivity at high temperatures, the bulk and grain boundary contributions to the total resistance of the sample may be separated out.
In preparing these new electrolyte compositions, a parent electrolyte material may have a molar ratio of zirconia (ZrO2):scandia (Sc2O3) that is around 89:11, such as 87-91:13-9. In an embodiment, zirconia may be doped with magnesia (MgO), or other ionic oxide with an aliovalent cation (e.g., Mg2+), up to 11% mole percent (mol %), while keeping the atomic percent of either Sc or Zr constant. In other embodiments, zirconia may be doped with a combination of one or more of magnesia, yttria, zinc oxide, and/or indium oxide. In other embodiments, zirconia may be doped with a combination of one or more of magnesia, yttria, and gallium oxide.
In an embodiment, magnesia may be used as a dopant that replaces scandia in scandia stabilized zirconia. Four example series of compositions are discussed in further detail below.
One example series of compositions (“A-series”) may be prepared based on the composition of 11 mol % Sc2O3, and may have a formula of Zr0.802Sc0.198-xMgxO1.90-0.5x. A ternary phase diagram showing the compositions of this example A-series is illustrated in
In this example series, at x=0, no Sc3+ ions are replaced, and therefore the atomic percent of Sc3+ ions is equal to the atomic percent in the parent material (i.e., 19.8%). At the highest x value tested (x=0.36), the atomic percent of scandium ions becomes the lowest (i.e., 16.2%).
Another example series of compositions (“B-series”) may be prepared based on the composition of 11 mol % Sc2O3. A formula for the B-series compositions may be Zr0.802+xSc0.198-2xMgxO1.90
In this example series, at x=0, no Sc3+ ions are replaced, and therefore the atomic percent of Sc3+ ions is equal to the atomic percent in the parent material (i.e., 19.8%). At the highest x value tested (x=0.036), the atomic percent of scandium ions is the lowest (i.e., 12.6%). A ternary phase diagram showing the compositions of this example B-series is illustrated in
Other example series of compositions (“G-series” and “H-series”) may maintain constant scandia content and increase magnesia levels by replacing Zr ions with Mg ions, thereby lowering the levels of zirconium and oxygen. The example G-series of compositions may be prepared based on a parent composition with 5.3 mol % Sc2O3, and may have a formula of Zr0.9-xSc0.1MgxO1.95-x. A ternary phase diagram showing the compositions in this example G-series is illustrated in
At x=0, no Mg2+ ions are added, and therefore the atomic percent of Sc3+ ions is equal to the atomic percent in the parent material (i.e., 10.0%). At the highest x value (x=0.10), the atomic percent of zirconium ions is the lowest (i.e., 80.0%).
Another example series of compositions (“H-series”) may be prepared based on a parent composition of 8.1 mol % Sc2O3. The H-series compositions may have a formula Zr0.85-xSc0.15MgxO1.925-x. A ternary phase diagram showing the example H-series compositions is illustrated in
X-ray diffraction patterns may determine the stable phase at room temperature for each magnesia doped scandia stabilized zirconia composition. The phases at room temperature for compositions in the example A-, B-, G-, and H-series of compositions are shown in Table 1 below:
Previous studies of the parent composition A0, B0 of the A and B-series, 11 mol % Sc2O3, have found it to have a rhombohedral structure at room temperature. At the lowest level of doping in the A-series of compositions (x=0.09), the structure may remain rhombohedral, while at all other doping levels the cubic fluorite structure may be stable. For the example B-series, all compositions may have a tetragonal fluorite structure.
X-ray analysis of the magnesium free G0 sample showed both tetragonal and monoclinic fluorite phases to be present, consistent with findings by Ruh et al. (Ruh 1977), in their study.
With respect to the H-series of compositions, additions of MgO with between 2.5 and 7.5 at. % magnesium stabilize the cubic phase. When the magnesium content is increased to 2.5 at. % the structure may remain tetragonal, but when the magnesium content is further increased to 5.0 and 7.5 at. %, the cubic structure may be stabilized. A further increase in magnesium content to 10 at. % tetragonal structure may become stable. This is shown in
Regarding the G-series of compositions, conductivity may remain less than 100 m/Scm across the entire range of compositions. These relatively low conductivities may be consistent with XRD results that show the presence of unwanted low conductivity monoclinic phases at room temperature. These low results may also indicate that G-series levels of magnesia and scandia are likely insufficient to stabilize the more conductive cubic phase of zirconia at 850° C. In contrast, the example H-series of compositions may show conductivities above 150 mS/cm, such as 150-199 mS/cm at compositions with 5.0 at. % magnesium or less. The conductivity may increase approximately linearly with magnesia content to a peak value of 199 mS/cm for the H2 sample, (5.0 at. % magnesium). A further increase to 7.5 at. % magnesium may lead to a large drop in conductivity to 79 mS/cm.
When the magnesium content of the H-series of compositions is increased from 5 at. % to 7.5 at. % or higher, a large decrease in conductivity may be observed.
In order to further decrease the level of scandia, two additional series of compositions based on the B1.5 and B3 compositions may be developed.
In another embodiment, scandia stabilized zirconia compositions may be co-doped with magnesia and yttria. An example series of compositions (“E-series”) may be prepared based on a parent composition of 10.7 mol % Sc2O3. The E-series may have a formula Zr0.815Sc0.171-xYxMg0.0135O1.90. In this series of compositions, one Y3+ ion replaces one scandium ion, while zirconium, magnesium and oxygen levels remain constant. The x values that may be used to form the E-series compositions were: 0, 0.018, 0.036, 0.054, and 0.072, thereby creating the following E-series compositions:
Another example series of compositions (“F-series”) may be prepared based on a parent composition of 7.9 mol % Sc2O3. The F-series may have a formula Zr0.829Sc0.144-xYxMg0.027O1.90. The x values that may be used to prepare the F-series compositions are: 0, 0.018, 0.036, 0.054, and 0.072, thereby creating the following compositions:
In this series of compositions, like in the E-series, one Y3+ ion replaces one scandium ion, while zirconium, magnesium and oxygen levels remain constant. At x=0, no scandium ions are replaced, and the atomic percent of scandium is equal to the parent composition (i.e., 14.4%). At the highest x value, x=0.072, atomic percent of scandium is lowest of the series (i.e., 7.2%). A ternary phase diagram of the example E- and F-series compositions is illustrated in
The XRD patterns of the example in the E-series and F-series compositions are shown in
In another embodiment, scandia stabilized zirconia compositions that are similar to the B-series compositions may be doped with either zinc oxide (ZnO) or indium oxide (In2O3), instead of or in addition to magnesia.
In an example series of compositions (“B—Zn series”), which may be based on the B1.5 sample composition discussed above, zinc ions may replace magnesium ions. The B—Zn series may have a formula of Zr0.802+xSc0.198-2xZnxO1.90. X values that may be used to prepare this B—Zn series of compositions are: 0, 0.0135 (corresponding to B1.5) and 0.027 (corresponding to B3), thereby creating the following compositions:
Specifically, in this series, two Sc3+ ions may be replaced by one Zn2+ and one Zr4+ ion. The oxygen stoichiometry remains constant as Sc3+ is replaced by these ions. XRD patterns for sample compositions in this B—Zn series of compositions are illustrated in
The conductivities at 850° C. of the B—Zn series compositions, compared to corresponding B-series compositions and the parent composition with 11 mol % Sc2O3, are provided in Table 3 below:
In another example series of compositions, indium oxide may be used as a co-dopant with scandia. Similar to the A-series of compositions in which Mg2+ is a co-dopant that replaces Sc3+, in an In2O3 co-doped composition the In3+ ions may replace Sc3+ ions in a 1:1 ratio, with the oxygen content remaining fixed. This series may be based on a parent composition of 11 mol % Sc2O3, and may have a formula of: Zr0.802Sc0.198-xInxO1.90 where 0≤x≤0.198, such as 0.018≤x≤0.18.
Sample compositions of this embodiment may have 0-11 mol % Sc2O3, such as 1-9 mol % Sc2O3, and 0-11 mol % In2O3, such as 2-10 mol % In2O3, with a total doping range (i.e., sum of Sc2O3 and In2O3 mole percentages) of 11 mol %. In one example, the composition may have 9 mol % Sc2O3 and 2 mol % In2O3, and therefore have a formula of Zr0.802Sc0.162In0.036O1.90.
In another embodiment, scandia stabilized zirconia compositions that are similar to the H-series compositions may be doped with indium oxide (In2O3) in addition to magnesia. In an example series of compositions (“H—In series”), which may be based on the H2 sample composition discussed above, Sc3+ ions may be replaced by Mg2+ ions in a 1:1 ratio, thereby lowering scandium and oxygen content of the composition while keeping zirconia and indium content constant. The H—In series may have a formula of Zr0.8Sc0.15-xIn0.05MgxO2-d, in which 0≤x≤0.05. The formula for the H—In series may also be written as Zr0.8Sc0.15-xIn0.05MgxOd, in which 1.8≤d≤2 and 0≤x≤0.05. At x=0, no magnesia is present and a sample composition has a formula Zr0.8Sc0.15In0.05O2-d. At x=0.05, a sample composition has a formula Zr0.8Sc0.10In0.05Mg0.05O2-d.
Another set of examples involves variants of the E1 sample composition, discussed above. In one example composition, zinc oxide may replace magnesia as a dopant, producing a composition “E1-Zn” that may have a formula Zr0.815Sc0.153Y0.0153Zn0.0135O1.90. In another example, In2O3 may be used as a co-dopant that replaces yttria, producing a composition “E1-In” that may have a formula Zr0.815Sc0.153In0.018Mg0.0135O1.90.
In further embodiments, scandia stabilized zirconia may be co-doped with gallium oxide and yttria. Without wishing to be bound to a particular theory, the combination of the smaller radius Ga3+ ion and the larger radius Y3+ may lead to less distortion of the crystal structure.
An example series of compositions (“I-series”) may be created with a formula Zr0.8018Sc0.1782Y0.02-xGaxO1.90. In this series of compositions, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium and oxygen levels remain constant. The x values that may be used to form the I-series compositions are: 0, 0.005, 0.01, 0.015 and 0.02, thereby creating the following compositions:
At x=0, no yttrium ions are replaced, and no gallium ions are present. At the highest x value, x=0.02, all yttrium ions are replaced by gallium ions.
Another example series of compositions (“J-series”) may be prepared with a formula Zr0.802Sc0.188Y0.01-xGaxO1.90. In the J-series, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium and oxygen levels remain constant. The x values that may be used to form the J-series compositions are: 0, 0.0025, 0.005, 0.0075, thereby creating the following compositions:
At x=0, no yttrium ions are replaced, and no gallium ions are present. At the highest x value, x=0.0075, the composition contains 2.5 at. % Y3+ and 7.5 at. % Ga3+ ions.
Another example series of compositions (“K-series”) may be prepared with a formula Zr0.8018Sc0.1682Y0.03-xGaxO1.90. In this series of compositions, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium and oxygen levels remain constant. An x value that may be used to form an example K-series composition is 0.015, which may create a K2 sample composition having a formula Zr0.8018Sc0.1682Y0.015Ga0.015O1.90. At this x value, the atomic percentages of Y3+ ions and Ga3+ ions are equal.
Another example series of compositions (“L-series”) may be prepared with a formula Zr0.8018Sc0.1582Y0.04-xGaxO1.90. In this series of compositions, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium and oxygen levels remain constant. An x value that may be used to form an example L-series composition is 0.02, which may create a L2 sample composition having a formula Zr0.8018Sc0.1582Y0.02Ga0.02O1.90. At this x value, the atomic percentages of Y3+ ions and Ga3+ ions are equal.
D.C. conductivities of sample compositions I2, I3, J2, J3, K2 and L2 at 850° C. are provided in Table 4 below:
Another example series of compositions (“M-series”) may be prepared with a formula Zr0.815Sc0.15 Y0.02-xGaxMg0.015O1.9. In this series of compositions, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium, magnesium and oxygen levels remain constant. The x values that may be used to prepare the M-series are 0, 0.01 and 0.02, thereby creating the following compositions:
Another example series of compositions (“N-series”) may be created with a formula Zr0.815SC0.13Y0.04-xGaxMg0.015O1.90. In this series of compositions, one Ga3+ ion replaces one Y3+ ion, while zirconium, scandium, magnesium and oxygen levels remain constant. The x values that may used to make the N-series are 0, 0.01, 0.02, 0.03, and 0.04, thereby creating the following compositions:
At x=0, no yttrium ions are replaced, and no gallium is present, and at x=0.04, all yttrium ions are replaced with gallium ions.
In further embodiments, scandia stabilized zirconia may be co-doped with indium oxide and ceria. An example series of compositions (“O-series”) may be created with a formula Zr0.8o9Sc0.182-xCe0.009InxO2-d, where 0≤x≤0.164. This series may also be written as Zr0.809Sc0.182-xCe0.009InxOd, where 1.8≤d≤2 and 0≤x≤0.164. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material for the O-series of compositions may be 10Sc2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 9 mol % In2O3 (e.g., 9Sc2O3-1In2O3-1CeO2 to 1Sc2O3-9In2O3-1CeO2).
Other example compositions may be created with total dopant amounts lower than 11 mol %. For example, one series of compositions may be created with at least 8 mol %, such as 9 mol % of total dopant, and a formula Zr0.843Sc0.0926-xCe0.009In0.0556+xO2-d, where 0≤x≤0.0741. The formula for this series may also be written as Zr0.843Sc0.0926-xCe0.009In0.0556+xOd, where 1.8≤d≤2 and 0≤x≤0.0741. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material may comprise 5Sc2O3-3In2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 4 mol % In2O3 (e.g., 5Sc2O3-3In2O3-1CeO2 to 1Sc2O3-7In2O3-1CeO2). In another example, a series of compositions (“P-series”) may be created with 10 mol % of total dopant, and a formula Zr0.825Sc0.110-xCe0.009In0.055+xO2-d, where 0≤x≤0.0917. The formula for the P-series may also be written as Zr0.825Sc0.110-xCe0.009In0.055+xOd, where 1.8≤d≤2 and 0≤x≤0.0917. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material may be 6Sc2O3-3In2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 5 mol % In2O3 (e.g., 6Sc2O3-3In2O3-1CeO2 to 1Sc2O3-8In2O3-1CeO2). Some x values that may used to make the P-series are 0 and 0.018, thereby creating the following compositions:
At x=0, no additional scandium ions are replaced, and the amount of indium present is the same as in the parent dopant material.
Other embodiment compositions may be created with total dopant amounts that are higher than 11 mol %, such as up to 14 mol %. For example, one series of compositions (“Q-series”) may be created with 11.5 mol % of total dopant, and a formula Zr0.801Sc0.10-xCe0.009In0.091+xO2-d, where 0≤x≤0.082. The formula for the Q-series may also be written as Zr0.801Sc0.10-xCe0.009In0.091+xOd, where 1.8≤d≤2 and 0≤x≤0.082. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material may be 5.5Sc2O3-5In2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 4.5 mol % In2O3 (e.g., 5.5Sc2O3-5In2O3-1CeO2 to 1Sc2O3-9.5In2O3-1CeO2). Some x values that may used to make the Q-series are 0 and 0.010, thereby creating the following compositions:
At x=0, no additional scandium ions are replaced, and the amount of indium present is the same as in the parent dopant material.
In another example, a series of compositions (“R-series”) may be created with 12 mol % of total dopant, and a formula Zr0.793Sc0.110-xCe0.009In0.090+xO2-d, where 0≤x≤0.09. The formula for the R-series may also be written as Zr0.793Sc0.110-xCe0.009In0.090+xOd, where 1.8≤d≤2 and 0≤x≤0.09. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material may be 6Sc2O3-5In2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 5 mol % In2O3 (e.g., 6Sc2O3-5In2O3-1CeO2 to 1Sc2O3-10In2O3-1CeO2). Some x values that may used to make the R-series are 0, 0.009, and 0.018, thereby creating the following compositions:
At x=0, no additional scandium ions are replaced, and the amount of indium present is the same as in the parent dopant material.
In another embodiment, a related series of compositions (R′-series) also having a total of 12 mol % dopant may be created with scandia stabilized zirconia that is co-doped only with indium, and lacks cerium or ceria. The R′-series may have a formula Zr0.786Sc0.143-xIn0.071+xO2-d, where 0≤x≤0.125. The formula for the R′-series may also be written as Zr0.786Sc0.143-xIn0.071+xOd, where 1.8≤d≤2 and 0≤x≤0.125. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium and oxygen levels remain constant. A parent dopant material may be 8Sc2O3-4In2O3. Sample compositions may be created by replacing Sc2O3 with up to 7 mol % In2O3 (e.g., 8Sc2O3-4In2O3 to 1Sc2O3-11In2O3). Some x values that may used to make the R-series are 0 and 0.036, thereby creating the following compositions:
At x=0, no additional scandium ions are replaced, and the amount of indium present is the same as in the parent dopant material. At x=0.036, the amounts of indium and scandium are equal in the dopant material.
In another example, a series of compositions (“S-series”) having 13 mol % of total dopant may be created using scandia stabilized zirconia co-doped with indium oxide and ceria. The S-series may have a formula Zr0.777Sc0.107-xCe0.009In0.107+xO2-d, where 0≤x≤0.089. The formula for the S-series may also be written as Zr0.777Sc0.107-xCe0.009In0.107+xOd, where 1.8≤d≤2 and 0≤x≤0.089. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium, cerium, and oxygen levels remain constant. A parent dopant material may be 6Sc2O3-6In2O3-1CeO2. Sample compositions may be created by replacing Sc2O3 with up to 5 mol % In2O3 (e.g., 6Sc2O3-6In2O3-1CeO2 to 1Sc2O3-11In2O3-1CeO2). Some x values that may used to make the S-series are 0 and 0.018, thereby creating the following compositions:
In another embodiment, a related series of compositions (S′-series) also having a total of 13 mol % dopant may be created with scandia stabilized zirconia that is co-doped only with indium. The S′-series may have a formula Zr0.770Sc0.142-xIn0.088+xO2-d, where 0≤x≤0.125. The formula for the S′-series may also be written as Zr0.770Sc0.142-xIn0.088+xOd, where 1.8≤d≤2 and 0≤x≤0.125. In this series of compositions, In3+ ions replace Sc3+ ions in a 1:1 ratio, while zirconium and oxygen levels remain constant. A parent dopant material may be 8Sc2O3-5In2O3. Sample compositions may be created by replacing Sc2O3 with up to 7 mol % In2O3 (e.g., 8Sc2O3-5In2O3 to 1Sc2O3-12In2O3).
As shown by the data plots, D.C. conductivity of the samples may be a value between 80 mS/cm and 220 mS/cm. As also shown by the data plot, a peak D.C. conductivity level of at least 215 mS/cm, such as between 215 and 220 mS/cm, may be achieved in the O-series in a sample with around 16.3 at. % scandium, and around 1.8 at % indium, which has a sample formula of around Zr0.809Sc0.163Ce0.009In0.018O1.9. The amounts of scandium and indium at the peak D.C. conductivity level correspond to a dopant material of 9 mol % Sc2O3, 1 mol % In2O3, and 1 mol % CeO2. Thus, the O-series this series may be described as having a formula Zr1-w-y-zScwCezInyOd, in which 0.072≤w≤0.182, in which 0≤y≤0.1098, in which 0.008≤z≤0.1, and in which 1.8≤d≤2. In an embodiment, scandium ion concentration (w) may be characterized by w=0.182−y, and cerium ion concentration (z) may be characterized by z=0.009. In another embodiment, indium ion concentration (y) may be characterized by y=0.018.
As demonstrated in the various example series of scandia stabilized zirconia compositions, the B- and H-series compositions may have high relative conductivities. For example, a sample B1.5 composition may have a D.C. conductivity of 232 mS/cm. In another example, sample H2 and H1 compositions may have D.C. conductivities of 199 mS/cm and 171 mS/cm, respectively.
In another example, a sample K2 composition may have a relatively high conductivity of 145 mS/cm. In another example, a sample L2 composition may also have a relatively high conductivity of 145 mS/cm. In another example, compositions doped In2O3 may have relatively high conductivities around 195 mS/cm.
The compositions above may be used for a solid oxide fuel cell electrolyte. The electrolyte may be plate shaped with an anode electrode on one side (e.g., a nickel and stabilized zirconia and/or doped ceria cermet) and a cathode electrode (e.g., lanthanum strontium manganate) on the opposite side. The fuel cell comprising the electrolyte, anode and cathode electrodes may be located in a fuel cell stack. The term “fuel cell stack,” as used herein, means a plurality of stacked fuel cells separated by interconnects which may share common air and fuel inlet and exhaust passages, manifolds or risers. The “fuel cell stack,” as used herein, includes a distinct electrical entity which contains two end plates which are connected to power conditioning equipment and the power (i.e., electricity) output of the stack. Thus, in some configurations, the electrical power output from such a distinct electrical entity may be separately controlled from other stacks. The term “fuel cell stack” as used herein, also includes a part of the distinct electrical entity. For example, the stacks may share the same end plates. In this case, the stacks jointly comprise a distinct electrical entity, such as a column. In this case, the electrical power output from both stacks cannot be separately controlled.
The formulas that represent the compositions above are not intended to limit the scope of the invention to particular atomic or mole percentages, but are provided to facilitate disclosure of the various series of related compositions. For example, the representation of oxygen as “O2-d” or “Od” provides for a variable amount of oxygen that may depend, for example, on the total amount of doping, valence of cations in the composition, etc. Example amounts of oxygen that may be present in series of compositions discussed above include, without limitation: 1.92 at % oxygen in the P-series; 1.91 at % oxygen in the Q-series, 1.90 at % oxygen in the R-series; 1.89 at % oxygen in the R′-series; and 1.87 at % oxygen in the S-series.
The foregoing description of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form disclosed, and modifications and variations are possible in light of the above teachings or may be acquired from practice of the invention. The description was chosen in order to explain the principles of the invention and its practical application. It is intended that the scope of the invention be defined by the claims appended hereto, and their equivalents.
Number | Name | Date | Kind |
---|---|---|---|
4052532 | Tannenberger et al. | Oct 1977 | A |
4272353 | Lawrance et al. | Jun 1981 | A |
4426269 | Brown et al. | Jan 1984 | A |
4459340 | Mason | Jul 1984 | A |
4575407 | Diller | Mar 1986 | A |
4686158 | Nishi et al. | Aug 1987 | A |
4791079 | Hazbun | Dec 1988 | A |
4792502 | Trocciola et al. | Dec 1988 | A |
4804592 | Vanderborgh et al. | Feb 1989 | A |
4847173 | Mitsunaga et al. | Jul 1989 | A |
4898792 | Singh et al. | Feb 1990 | A |
4913982 | Kotchick et al. | Apr 1990 | A |
4917971 | Farooque | Apr 1990 | A |
4925745 | Remick et al. | May 1990 | A |
4983471 | Reichner et al. | Jan 1991 | A |
5034287 | Kunz | Jul 1991 | A |
5047299 | Shockling | Sep 1991 | A |
5143800 | George et al. | Sep 1992 | A |
5162167 | Minh et al. | Nov 1992 | A |
5169730 | Reichner et al. | Dec 1992 | A |
5170124 | Blair et al. | Dec 1992 | A |
5171645 | Khandkar | Dec 1992 | A |
5192334 | Rohr et al. | Mar 1993 | A |
5213910 | Yamada | May 1993 | A |
5215946 | Minh | Jun 1993 | A |
5256499 | Minh et al. | Oct 1993 | A |
5273837 | Aiken et al. | Dec 1993 | A |
5290323 | Okuyama et al. | Mar 1994 | A |
5290642 | Minh et al. | Mar 1994 | A |
5302470 | Okada et al. | Apr 1994 | A |
5342705 | Minh et al. | Aug 1994 | A |
5368667 | Minh et al. | Nov 1994 | A |
5441821 | Merritt et al. | Aug 1995 | A |
5498487 | Ruka et al. | Mar 1996 | A |
5501914 | Satake et al. | Mar 1996 | A |
5505824 | McElroy | Apr 1996 | A |
5518829 | Satake et al. | May 1996 | A |
5527631 | Singh et al. | Jun 1996 | A |
5573867 | Zafred et al. | Nov 1996 | A |
5589017 | Minh | Dec 1996 | A |
5589285 | Cable et al. | Dec 1996 | A |
5601937 | Isenberg | Feb 1997 | A |
5686196 | Singh et al. | Nov 1997 | A |
5688609 | Rostrup-Nielsen et al. | Nov 1997 | A |
5733675 | Dederer et al. | Mar 1998 | A |
5741406 | Barnett et al. | Apr 1998 | A |
5741605 | Gillett et al. | Apr 1998 | A |
5922488 | Marucchi-Soos et al. | Jul 1999 | A |
5942349 | Badwal et al. | Aug 1999 | A |
5955039 | Dowdy | Sep 1999 | A |
5993989 | Baozhen | Nov 1999 | A |
6013385 | DuBose | Jan 2000 | A |
6051125 | Pham et al. | Apr 2000 | A |
6106964 | Voss et al. | Aug 2000 | A |
6228521 | Kim et al. | May 2001 | B1 |
6238816 | Cable et al. | May 2001 | B1 |
6280865 | Eisman et al. | Aug 2001 | B1 |
6287716 | Hashimoto et al. | Sep 2001 | B1 |
6329090 | McElroy et al. | Dec 2001 | B1 |
6361892 | Ruhl et al. | Mar 2002 | B1 |
6403245 | Hunt | Jun 2002 | B1 |
6436562 | DuBose | Aug 2002 | B1 |
6451466 | Grasso et al. | Sep 2002 | B1 |
6489050 | Ruhl et al. | Dec 2002 | B1 |
6495279 | Bogicevic et al. | Dec 2002 | B1 |
6558831 | Doshi et al. | May 2003 | B1 |
6582845 | Helfinstine et al. | Jun 2003 | B2 |
6592965 | Gordon | Jul 2003 | B1 |
6605316 | Visco | Aug 2003 | B1 |
6623880 | Geisbrecht et al. | Sep 2003 | B1 |
6677070 | Kearl | Jan 2004 | B2 |
6682842 | Visco et al. | Jan 2004 | B1 |
6767662 | Jacobson et al. | Jul 2004 | B2 |
6787261 | Ukai | Sep 2004 | B2 |
6803141 | Pham et al. | Oct 2004 | B2 |
6811913 | Ruhl | Nov 2004 | B2 |
6821663 | McElroy et al. | Nov 2004 | B2 |
6854688 | McElroy et al. | Feb 2005 | B2 |
6924053 | McElroy | Aug 2005 | B2 |
6972161 | Beatty et al. | Dec 2005 | B2 |
6979511 | Visco et al. | Dec 2005 | B2 |
7150927 | Hickey et al. | Dec 2006 | B2 |
7157173 | Kwon | Jan 2007 | B2 |
7255956 | McElroy et al. | Aug 2007 | B2 |
7494732 | Roy et al. | Feb 2009 | B2 |
7550217 | Kwon et al. | Jun 2009 | B2 |
7563503 | Gell et al. | Jul 2009 | B2 |
7601183 | Larsen | Oct 2009 | B2 |
8580456 | Armstrong et al. | Nov 2013 | B2 |
20010049035 | Haltiner, Jr. et al. | Dec 2001 | A1 |
20020012825 | Sasahara et al. | Jan 2002 | A1 |
20020014417 | Kuehnle et al. | Feb 2002 | A1 |
20020028362 | Prediger et al. | Mar 2002 | A1 |
20020028367 | Sammes et al. | Mar 2002 | A1 |
20020058175 | Ruhl | May 2002 | A1 |
20020098406 | Huang et al. | Jul 2002 | A1 |
20020106544 | Noetzel et al. | Aug 2002 | A1 |
20020127455 | Pham et al. | Sep 2002 | A1 |
20020132156 | Ruhl et al. | Sep 2002 | A1 |
20030162067 | McElroy | Aug 2003 | A1 |
20030165732 | McElroy | Sep 2003 | A1 |
20030196893 | McElroy et al. | Oct 2003 | A1 |
20040081859 | McElroy et al. | Apr 2004 | A1 |
20040191595 | McElroy et al. | Sep 2004 | A1 |
20040191597 | McElroy | Sep 2004 | A1 |
20040191598 | Gottmann et al. | Sep 2004 | A1 |
20040202914 | Sridhar et al. | Oct 2004 | A1 |
20040224193 | Mitlitsky et al. | Nov 2004 | A1 |
20040229031 | Gell et al. | Nov 2004 | A1 |
20040265484 | Pham et al. | Dec 2004 | A1 |
20040265663 | Badding et al. | Dec 2004 | A1 |
20050048334 | Sridhar et al. | Mar 2005 | A1 |
20050074650 | Sridhar et al. | Apr 2005 | A1 |
20050164051 | Venkataraman et al. | Jul 2005 | A1 |
20050214616 | Kumar et al. | Sep 2005 | A1 |
20050227134 | Nguyen | Oct 2005 | A1 |
20050271919 | Hata et al. | Dec 2005 | A1 |
20060008682 | McLean et al. | Jan 2006 | A1 |
20060040168 | Sridhar | Feb 2006 | A1 |
20060110633 | Ukai et al. | May 2006 | A1 |
20060166070 | Hickey et al. | Jul 2006 | A1 |
20060199057 | Hiwatashi | Sep 2006 | A1 |
20060216575 | Cassidy | Sep 2006 | A1 |
20060222929 | Hickey et al. | Oct 2006 | A1 |
20070045125 | Hartvigsen et al. | Mar 2007 | A1 |
20070082254 | Hiwatashi | Apr 2007 | A1 |
20070141422 | Brown | Jun 2007 | A1 |
20070141423 | Suzuki et al. | Jun 2007 | A1 |
20070141443 | Brown | Jun 2007 | A1 |
20070141444 | Brown | Jun 2007 | A1 |
20070224481 | Suzuki et al. | Sep 2007 | A1 |
20070237999 | Donahue et al. | Oct 2007 | A1 |
20070275292 | Sin Xicola et al. | Nov 2007 | A1 |
20070287048 | Couse et al. | Dec 2007 | A1 |
20080029388 | Elangovan et al. | Feb 2008 | A1 |
20080075984 | Badding et al. | Mar 2008 | A1 |
20080076006 | Gottmann et al. | Mar 2008 | A1 |
20080096080 | Batawi et al. | Apr 2008 | A1 |
20080102337 | Shimada | May 2008 | A1 |
20080254336 | Batawi | Oct 2008 | A1 |
20080261099 | Nguyen et al. | Oct 2008 | A1 |
20090029195 | Gauckler et al. | Jan 2009 | A1 |
20090068533 | Fukusawa et al. | Mar 2009 | A1 |
20090186250 | Narendar et al. | Jul 2009 | A1 |
20090214919 | Suzuki | Aug 2009 | A1 |
20090291347 | Suzuki | Nov 2009 | A1 |
20090305106 | Gell et al. | Dec 2009 | A1 |
20110039183 | Armstrong et al. | Feb 2011 | A1 |
20110183233 | Armstrong et al. | Jul 2011 | A1 |
20120231368 | Hata | Sep 2012 | A1 |
20140051010 | Armstrong et al. | Feb 2014 | A1 |
20140141344 | Miller et al. | May 2014 | A1 |
Number | Date | Country |
---|---|---|
101147285 | Mar 2008 | CN |
101295792 | Oct 2008 | CN |
102725902 | Oct 2012 | CN |
1048839 | Nov 1966 | GB |
3196465 | Aug 1991 | JP |
H06150943 | May 1994 | JP |
6215778 | Aug 1994 | JP |
2000-340240 | Aug 2000 | JP |
2000-281438 | Oct 2000 | JP |
2003068324 | Mar 2003 | JP |
2004087490 | Mar 2004 | JP |
2007-026874 | Feb 2007 | JP |
2007026874 | Feb 2007 | JP |
2008502113 | Jan 2008 | JP |
2008189838 | Aug 2008 | JP |
2008-305804 | Dec 2008 | JP |
2009059699 | Mar 2009 | JP |
20020092223 | Dec 2002 | KR |
20070095440 | Sep 2007 | KR |
20080010737 | Jan 2008 | KR |
20080097971 | Nov 2008 | KR |
100886239 | Feb 2009 | KR |
20090061870 | Jun 2009 | KR |
WO2004093214 | Oct 2004 | WO |
WO2005041329 | May 2005 | WO |
WO2008019926 | Feb 2008 | WO |
WO2009097110 | Aug 2009 | WO |
Entry |
---|
JPH06150943 A—Machine Translation (Year: 1992). |
Republic of China (Taiwan) Office Communication for Taiwanese Patent Application No. 102142390, dated Jan. 19, 2017, 5 pages. |
State Intellectual Property Office (SIPO) issued a Third Office Action for PRC (China) Patent Application No. 201380060253.1, dated Dec. 21, 2017, 4 pages. |
Second Office Action Issued by State Intellectual Property Office for Chinese Patent Application No. 201380060253.1, dated Apr. 27, 2017, 14 pages including English-language translation. |
Ahmad-Khantou et al., “Electrochemical & Microstructural Study of SOFC Cathodes Based on La0.5Sr0.3MnO3 and Pro0.65Sr0.3MnO3,” Electrochemical Society Proceedings, 2001, p. 476-485, vol. 2001-16. |
Mori et al., “Lanthanum Alkaline-Earth Manganites as a Cathode Material in High-Temperature Solid Oxide Fuel Cells,” Journal of the Electrochemical Society, 1999, p. 4041-4047, vol. 146. |
L.G. Austin, “Cell & Stack Construction: Low Temperature Cells,” NASA SP-120, 1967. |
EG & G Services, Parsons, Inc., SAIC, Fuel Cell Handbook, 5th Edition, USDOE, Oct. 2000, p. 9-1-9.4, and 9-12-9-14. |
J.M. Sedlak, et al., “Hydrogen Recovery and Purification Using the Solid Polymer Electrolyte Electrolysis Cell,” Int. J. Hydrogen Energy, vol. 6, p. 45-51, 1981. |
Dr. Ruhl, “Low Cost Reversible Fuel Cell System,” Proceedings of the 2000 U.S. DOE Hydrogen Program Review, Jun. 15, 2000, NREL/CP-570-30535. |
Low Cost, Compact Solid Oxide Fuel Cell Generator, NASA Small Business Innovation Research Program, 2001. |
Low Cost, High Efficiency Reversible Fuel Cell (and Electrolyzer) Systems, Proceedings of the 2001 DOE Hydrogen Program Review NREL/CP-570-30535. |
Milliken et al., “Low Cost, High Efficiency Reversible Fuel Cell Systems,” Proceedings of the 2002 U.S. DOE Hydrogen Program Review, NREL/CP-610-32405. |
K. Eguchi et al., Power Generation and Steam Electrolysis Characteristics of an Electrochemical Cell with a Zirconia or Ceria based Electrode, Solid State Ionics, 86 88, 1996, p. 1245-49. |
F. Mitlitsky et al., “Regenerative Fuel Cells for High Altitude Long Endurance Solar Powered Aircraft,” 28th Intersociety Energy Conversion Engineering Conference (IECED), Jul. 28, 1993, UCRL-JC-113485. |
Small, Ultra Efficient Fuel Cell Systems, Advanced Technology Program, ATP 2001 Competition, Jun. 2002. |
F. Mitlitsky et al., Unitized Regenerative Fuel Cells for Solar Rechargeable Aircraft and Zero Emission Vehicles, 1994 Fuel Cell Seminar, Sep. 6, 1994, UCRL-JC-117130. |
Ralph et al., “Cathode Materials for Reduced-Temperature SOFCs,” Journal of the Electrochemical Society, 2003, p. A1518-A1522, vol. 150. |
Simmer et al., “Development of Fabrication Techniques and Electrodes for Solid Oxide Fuel Cells,” Electrochemcial Society Proceedings, p. 1050-1061, vol. 2001-16. |
Yamamoto et al., “Electrical Conductivity of Stabilized Zirconia with Ytterbia and Scandia,” Solid State Ionics, v79, p. 137-142, Jul. 1995. |
Araki et al., “Degradation Mechanism of Scandia-Stabilized Zirconia Electrolytes: Discussion based on Annealing Effects on Mechanical Strength, Ionic Conductivity, and Raman Spectrum,” Solid State Ionics, v180, n28-31, p. 1484-1489, Nov. 2009. |
Lybye et al., “Effect of Transition Metal Ions on the Conductivity and Stability of Stabilized Zirconia,” Ceramic Engineering and Science Proceedings, v27, n4, p. 67-78, 2006. |
International Preliminary Report on Patentability, International Application No. PCT/US2011/021664, dated Aug. 9, 2012. |
International search report and written opinion received in connection with International Application No. PCT/US2013/070783, dated Mar. 10, 2014. |
Chinese Office Action received in connection with Chinese Patent Application No. 201180006935.5, dated Jun. 13, 2014 (English translation also provided). |
Taiwan Office Action received in connection with Taiwan Patent Application No. 100102963, dated May 6, 2014 (English translation also provided). |
Taiwan Search Report received in connection with Taiwan Patent Application No. 100102963, dated May 6, 2014 (English translation also provided). |
International Search Report, International Application No. PCT/US2011/021664, dated Sep. 28, 2011. |
International preliminary report on patentability received in connection with International Application No. PCT/US2013/070783, dated Jun. 4, 2015. |
State Intellectual Property Office (SIPO) First Office Action for PRC (China) Patent Application No. 201380060253.1, dated Sep. 2, 2016, 11 pages. |
Office Action from the Republic of China (Taiwan) Intellectual Property Office for Taiwanese Patent Application No. 106134369, dated Mar. 7, 2018, 2 pages. |
English-language Translation of the Search Report from Republic of China (Taiwan) Office Communication for Taiwanese Patent Application No. 106134369, dated Mar. 7, 2018, 1 page. |
Japan Patent Office, Office Communication, Notice of Reasons for Rejection for Japanese Patent Application No. 2015-543115, dated Sep. 7, 2017, 4 pages. |
Taiwanese Office Action from the Intellectual Property Office of ROC (Taiwan) for Patent Application No. 106134369, dated Sep. 25, 2018, and English Translation thereof. |
The Fourth Office Action from the State Intellectual Property Office (SIPO) for PRC (China) Patent Application No. 201380060253.1, dated May 28, 2018, 3 pages. |
Japan Office Communication, Notice of Reasons for Rejection and Its Brief Summary for Japanese Patent Application No. 2018-091247, dated May 22, 2019, 5 pages including English-language translation. |
Number | Date | Country | |
---|---|---|---|
20170117567 A1 | Apr 2017 | US |
Number | Date | Country | |
---|---|---|---|
61792699 | Mar 2013 | US | |
61728270 | Nov 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14083708 | Nov 2013 | US |
Child | 15340625 | US |